B. D. HEDLEY ET AL. DXH 800 PERFORMANCE EVALUATION 55 R E F E R E N C E S Aulesa C., Pastor I., Naranjo D., Piqueras J. & Galimany R. (2003) Validation of the Coulter LH 750 in a hospital refer- ence laboratory. Laboratory Hematology 9, 15–28. Aulesa C., Pastor I., Naranjo D. & Galima- ny R. (2004) Application of receiver operating characteristics curve (ROC) analysis when deﬁnitive and suspect morphologic ﬂags appear in the New Coulter LH 750 Analyzer. Laboratory Hematology 10, 14–23. Bodey G.P. (2009) The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neu- tropenia: the early years. Journal of Antimicrobial Chemotherapy 63(Suppl 1), i3–i13. Bourner G., Dhaliwal J. & Sumner J. (2005) Performance evaluation of the latest fully automated hematology ana- lyzers in a large, commercial laboratory setting: a 4-way, side-by-side study. Laboratory Hematology 11, 285–297. Brown W., Kaplan S., Keeney M., John- son K., Wolfe N. & Chin-Yee I. (2001) Workﬂow improvement with random access and enhanced ﬂagging on the New Coulter LH 750 Hematology Ana- lyzer. Laboratory Hematology 7, 229– 235. Chin-Yee I., Keeney M., Johnson K., Brown W., Wolfe N. & Kaplan S. (2001) White blood cell ﬂagging rates of the coulter LH 750 analyzer compared with the Coulter Gen•S Hematology Analyzer. Laboratory Hematology 7, 211–216. Chin-Yee I., Brown W., Johnson K., Kee- ney M., Steele B., Wolfe N. & Kaplan S. (2002) Identiﬁcation and enumeration of nucleated red blood cells on the coulter LH 750. Laboratory Hematology 8, 210–217. Cosler L.E., Sivasubramaniam V., Agboola O., Crawford J., Dale D. & Lyman G.H. (2005) Effect of outpatient treatment of febrile neutropenia on the risk thresh- old for the use of CSF in patients with cancer treated with chemotherapy. Value Health 8, 47–52. Dranitsaris G., Rayson D., Vincent M., Chang J., Gelmon K., Sandor D. & Reardon G. (2008) Identifying patients at high risk for neutropenic complica- tions during chemotherapy for meta- static breast cancer with doxorubicin or pegylated liposomal doxorubicin: the development of a prediction model. American Journal of Clinical Oncology 31, 369–374. Fernandez T., Domack L.B., Montes D., Pineiro R., Landrum E. & Vital E. (2001) Performance evaluation of the coulter LH 750 hematology analyzer. Laboratory Hematology 7, 217–228. Ghys T., Malfait R. & J V.A.N.d.B. (2009) Performance evaluation of the Sysmex XS-1000i automated haematology ana- lyser. International Journal of Labora- tory Hematology 31, 560–566. Hanseler E., Fehr J. & Keller H. (1996) Estimation of the lower limits of man- ual and automated platelet counting. American Journal of Clinical Pathology 105, 782–787. Harrison P., Horton A., Grant D., Briggs C. & MacHin S. (2000) Immunoplatelet counting: a proposed new reference procedure. British Journal Haematology 108, 228–235. Harrison P., Segal H., Briggs C., Murphy M. & Machin S. (2005) Impact of immunological platelet counting (by the platelet/RBC ratio) on haematological practice. Cytometry. Part B, Clinical Cytometry 67, 1–5. ISLH (1994) International Council for Standardization in Hematology. Guide- lines for evaluation of blood cell analyz- ers including those used for differential leukocyte and reticulocyte counting and cell marker application. Clinical and Laboratory Haematology, 16, 157–174. Kaplan S.S., Johnson K. & Wolfe N. (2001) Validation of low platelet counts from coulter LH 750 and Coulter Gen•S Analyzers. Laboratory Hematology 7, 198–203. Keeney M., Brown W. & Chin-Yee I. (2001) Platelet counts and ﬂagging rates from the LH 750 hematology analyzer compared with the ICSH/ISLH platelet reference method and the Gen•S Hema- tology Analyzer. Laboratory Hematology 7, 204–210. Kho A.N., Hui S., Kesterson J.G. & McDonald C.J. (2007) Which observa- tions from the complete blood cell count predict mortality for hospitalized patients? Journal of Hospital Medicine 2, 5–12. Koepke J.A., Van Assendelft O.W., Brindza L.J., Davis B., Fernandes B., Gewirtz A.S. & Rabinovitch A. (2007) Reference leukocyte (WBC) differential count (proportional) and evaluation of instrumental methods; approved stan- dard, 2nd edn. Clinical and Laboratory Standards Institute, Pennsylvania. La Porta A.D., Bowden A.S. & Barr S. (2002) Impact of the coulter LH 750 on productivity, turnaround time, and work ﬂow in a core laboratory. Labora- tory Hematology 8, 218–224. Muller R., Mellors I., Johannessen B., Aarsand A.K., Kiefer P., Hardy J., Kendall R. & Scott C.S. (2006) Euro- pean multi-center evaluation of the Abbott Cell-Dyn sapphire hematology analyzer. Laboratory Hematology 12, 15–31. Navarro J.T., Hernandez J.A., Ribera J.M., Sancho J.M., Oriol A., Pujol M., Milla F. & Feliu E. (1998) Prophylactic plate- let transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL. Haematologica 83, 998–1000. Nevo S., Fuller A.K., Hartley E., Borinsky M.E. & Vogelsang G.B. (2007) Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L. Transfusion 47, 801–812. Oka S., Muroi K., Mori M., Matsuyama T., Fujiwara S., Oh I., Ono Y., Kikuchi S., Sato K., Ueda M., Toshima M., Ozaki K., Takatoku M., Nagai T. & Oza- wa K. (2007) Evaluation of platelet transfusion thresholds in patients with acute myeloblastic leukemia receiving induction chemotherapy. Internal Medi- cine 46, 1669–1670. Richardson Jones A., Cornbleet J., Hou- wen B., Van Hove L., Koepke J.A., Sim- son E., Swaim W.R. & Van Assendelft O.W. (1996) Performance goals for the internal quality control of multichannel hematology analyzers; approved stan- dard. Clinical and Laboratory Standards Institute, Pennsylvania. Sagmeister M., Oec L. & Gmur J. (1999) A restrictive platelet transfusion pol- icy allowing long-term support of 2010 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem. 2011, 33, 45–56